When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. “This is an exciting moment,” Avid CEO Wellford Dillard said. “Wolftech is unquestionably on the ...
This week, biologics CDMO Avid Bioservices revealed that it’s agreed to be acquired by funds managed by Ampersand and British healthcare investment firm GHO Capital Partners in an all-cash deal ...
Under the terms of the merger agreement, GHO and Ampersand would acquire all the outstanding shares held by Avid’s stockholders for $12.50 per share in cash. The per share purchase price ...
Avid is a contract development and manufacturing organisation focused on biotechnology services. Credit: totojang1977/Shutterstock. Funds managed by GHO Capital ...
Anglo-US contract development and manufacturing organisation (CDMO) Avid Bioservices has agreed a deal to be acquired by private equity firms GHO Capital Partners and Ampersand Capital Partners.
Avid, a specialist in software solutions for professional media production, has completed the acquisition of Wolftech Broadcast Solutions, a player in cloud-based multiplatform news planning, ...
Nov 6 (Reuters) - Avid Bioservices (CDMO.O), opens new tab said on Wednesday that it would be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in a deal valued at ...
Avid Bioservices (NASDAQ:CDMO) has agreed to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners through a cash deal that values the company at around $1.1B.
Ampersand Capital Partners and GHO Capital Partners said they would take biopharmaceutical company Avid Bioservices CDMO0.16%increase; green up pointing triangle private in a $1.1 billion deal.